Commission and EIB provide CureVac with a €75 million financing for vaccine development and expansion of manufacturing

This article is brought to you in association with the European Commission. European Investment Bank and CureVac sign €75 million loan agreement for the development and large-scale production of vaccines, including CureVac’s vaccine candidate against SARS-CoV-2 The EIB loan will support CureVac’s activities to complete its new messenger ribonucleic acid (mRNA) production facility in Tübingen, Germany […]